Altimmune, Inc. (ALT)
3.54
+0.04
(+1.14%)
USD |
NASDAQ |
Mar 06, 16:00
3.57
+0.03
(+0.85%)
After-Hours: 20:00
Altimmune SG&A Expense (TTM) : 28.10M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| CorMedix, Inc. | 60.19M |
| Amgen, Inc. | 7.05B |
| Viking Therapeutics, Inc. | 48.39M |
| Verastem, Inc. | 56.70M |